Blog

Wegovy — the weight-loss branded formulation of semaglutide — has become one of the most widely prescribed medications for chronic weight management. As its use has grown, so has a question patients increasingly ask before or shortly after starting treatment:

Does Wegovy cause hair loss?

The short answer is yes, hair shedding can occur — and it is more common than many patients expect. But the mechanism is important to understand: Wegovy itself does not damage hair follicles. The hair loss most patients experience is a response to rapid weight loss and the nutritional changes that accompany it.

Below we explain why this happens, what you can do to reduce the risk, and when it makes sense to see a physician.

What Is Wegovy?

Wegovy is a high-dose injectable formulation of semaglutide, a GLP-1 receptor agonist. It is the same active ingredient as Ozempic, but approved specifically for chronic weight management rather than diabetes. Wegovy is administered once weekly and works by reducing appetite and slowing gastric emptying, helping patients consume less food overall.

Because Wegovy is designed specifically for weight loss — and because patients often achieve significant weight reduction on it, sometimes 15% or more of body weight within a year — the conditions that trigger hair shedding are frequently present.

Why Wegovy Can Cause Hair Loss

The type of hair loss most commonly seen with Wegovy is called telogen effluvium — a temporary, diffuse shedding triggered by physiologic stress rather than by the drug itself.

Hair follicles require a consistent supply of nutrients to remain in the active growth phase. When caloric and nutritional intake drops significantly, as often happens in the early months of Wegovy treatment, the body responds by redirecting resources toward organs it considers essential for survival. Hair, skin, and nails are deprioritized.

Many follicles shift prematurely into the resting phase. Several months later, those hairs shed — sometimes in noticeable quantities.

The most common triggers in Wegovy patients are:

• Rapid overall weight loss
• Reduced total caloric intake
• Insufficient protein consumption
• Deficiencies in iron, zinc, biotin, vitamin D, and B vitamins

Because the shedding typically begins two to four months after the triggering event, many patients are well into their Wegovy treatment before they notice it, leading some to assume the drug itself is the problem.

How Common Is Hair Loss on Wegovy?

Hair loss was reported in clinical trials for semaglutide at higher rates than placebo. In the STEP trials — the major clinical studies that supported Wegovy’s approval — hair loss was reported by approximately 3% of participants on semaglutide compared to under 1% on placebo.

However, real-world patient reports suggest the number may be higher, particularly among patients who lose weight rapidly or do not maintain adequate nutrition during treatment. The clinical trial figure likely reflects severe or noticeable shedding; more moderate thinning may go unreported.

Does Wegovy Cause More Hair Loss Than Ozempic?

Wegovy and Ozempic contain the same active ingredient — semaglutide — at different doses and for different indications. The mechanism of hair loss is identical.

The practical difference is that Wegovy patients, who are specifically pursuing significant weight loss, may lose weight more rapidly or in greater total amounts than patients using Ozempic primarily for blood sugar management. Because the degree and speed of weight loss drives the severity of telogen effluvium, some Wegovy patients experience more noticeable shedding — not because the drug is different, but because the weight loss goal may be more aggressive.

The Role of Nutrition

Maintaining adequate nutritional intake during Wegovy treatment is the single most important factor in preventing or minimizing hair shedding. This is harder than it sounds: Wegovy significantly suppresses appetite, and patients who are eating much less overall may not be getting enough of the specific nutrients hair follicles depend on.

Protein is the most critical. Hair is composed of keratin, a protein, and follicles require a steady supply of amino acids to maintain active growth. Many patients on GLP-1 medications eat less protein than they realize, particularly if their reduced appetite leads them toward lower-calorie, lower-protein choices. A general target of 60 to 100 grams of protein daily during active weight loss is commonly recommended.

Iron is the most commonly overlooked. Iron deficiency — even without frank anemia — is a well-documented trigger of hair shedding, especially in women. Patients losing weight rapidly should have ferritin levels checked, not just hemoglobin.

Zinc, biotin, and B vitamins support keratin synthesis and follicle cell function. Deficiencies are common in patients eating significantly restricted diets.

Vitamin D is associated with hair follicle cycling. Low levels are prevalent in the general population and can contribute to shedding independent of weight loss.

Practical steps: Prioritize protein at every meal. Choose nutrient-dense foods over simply eating less. Talk to your physician about baseline lab work and supplementation before or early in your Wegovy treatment.

Will Hair Grow Back?

For most patients, yes. Telogen effluvium is a temporary condition. Once weight loss slows and stabilizes and nutritional status improves, hair follicles typically return to the active growth phase. Most patients see meaningful regrowth over six to twelve months.

Several factors can delay or complicate recovery:

• Continued nutritional deficiencies
• Underlying pattern hair loss (androgenetic alopecia) that rapid weight loss has unmasked or accelerated
• Ongoing hormonal changes related to significant weight reduction
• Prolonged or severe caloric restriction

Patients who see continued or worsening shedding beyond six months, or who notice a pattern of thinning (rather than diffuse shedding across the whole scalp) should seek professional evaluation.

When Hair Loss May Not Be Temporary

Telogen effluvium and androgenetic alopecia (pattern hair loss) can occur at the same time — and rapid weight loss can sometimes accelerate pattern hair loss that was already developing beneath the surface.

The distinction matters because the treatments are different:

• Telogen effluvium resolves on its own with nutritional correction and time
• Androgenetic alopecia is progressive and does not resolve without treatment — options range from topical and oral medications to, in appropriate candidates, surgical hair restoration

If your shedding is severe, persistent, or accompanied by a recognizable thinning pattern at the crown or temples, a physician evaluation can determine what you are dealing with and what paths forward make sense.

How to Reduce the Risk of Hair Loss on Wegovy

• Aim for 60 to 100 grams of protein per day, spread across meals
• Choose nutrient-dense whole foods — do not just eat less, eat better
• Get labs checked before starting or early in treatment: ferritin, CBC, vitamin D, B12, zinc, thyroid panel
• Consider physician-guided supplementation: multivitamin, iron (if deficient), biotin, vitamin D
• Aim for steady, gradual weight loss rather than the fastest possible rate
• Avoid compounding stressors during the early months of treatment — other major dietary changes, illness, or extreme exercise can add to the physiologic burden

Hair Loss Evaluation in Dallas and Colleyville

If you are in the Dallas or Colleyville area and experiencing hair thinning while taking Wegovy or semaglutide, Dr. Jesse E. Smith, MD, FACS offers hair loss evaluation and hair restoration consultations at our Colleyville location.

Dr. Smith is a dual board-certified facial plastic and reconstructive surgeon with subspecialty expertise in surgical hair restoration. An evaluation with Dr. Smith goes beyond a checklist — it is a physician-level assessment of whether your hair loss is temporary, progressive, or a candidate for surgical restoration, conducted by a fellowship-trained surgeon rather than a sales consultant at a chain clinic.

We serve patients from Dallas, Colleyville, and the broader DFW area.

Schedule a hair restoration consultation

Key Takeaways

• Hair loss from Wegovy is common and typically related to rapid weight loss and reduced nutritional intake, not to semaglutide directly damaging hair follicles
• The most common mechanism is telogen effluvium — a temporary, diffuse shedding triggered by physiologic stress
• Adequate protein and micronutrient intake during treatment is the most important protective factor
• Most patients see hair recovery once weight loss stabilizes and nutrition improves
• Persistent, worsening, or patterned hair loss warrants professional evaluation to rule out underlying androgenetic alopecia
• Dallas and Colleyville patients can schedule a hair loss evaluation with Dr. Smith at our Colleyville practice

Jesse E. Smith, MD, FACS
Facial Plastic and Reconstructive Surgery
Otolaryngology-Head and Neck Surgery
Fort Worth and Colleyville, Texas